Pfizer's surprising news that its COVID-19 vaccine might offer more protection than anticipated—an announcement right after a fraught U.S. presidential election campaign—is raising questions about exactly how the different ...
Nov 9, 2020
0
0
A genetically edited form of a herpes simplex virus—rewired to keep it from taking refuge in the nervous system and eluding an immune response—has outperformed a leading vaccine candidate in a new study from the University ...
Nov 6, 2020
0
151
Where Aedes mosquitoes fly, Zika virus may not be far behind. Although the explosive 2015-2016 Zika epidemics in the Americas are behind us, Zika may re-emerge, and "in many countries, Zika may be spreading in silence," says ...
Nov 4, 2020
0
12
An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections. Designed ...
Nov 2, 2020
0
150
Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein. A rapidly reemerging tick-borne disease, ...
Oct 30, 2020
0
5
It has been a pandemic since at least biblical times, and unless effective strategies harness the global tuberculosis scourge, the disease will remain problematic and pervasive—an unending plague throughout many regions ...
Moderna said Thursday it took in $1.1 billion in deposits in the third quarter for a coronavirus vaccine that it is "actively preparing" to launch.
Oct 29, 2020
0
1
Drugmakers Sanofi and GSK said Wednesday they would set aside 200 million doses of a future coronavirus vaccine for a global initiative to ensure equitable distribution, including in poor countries.
Oct 28, 2020
0
2
Collaboration and standardised approaches for assessing different vaccine efficacy endpoints are key for meaningful comparison of different COVID-19 vaccine candidates to ensure that the most effective vaccines are deployed, ...
Oct 28, 2020
0
3
Prime Minister Justin Trudeau announced a deal Friday to procure 76 million doses of the first made-in-Canada COVID-19 vaccine candidate, enough for the entire population if it proves effective.
Oct 23, 2020
0
1
